Reference number : GC-2017-Q4-00138, amendment number : , agreement type : G, recipient legal name : Beauger, Nadine (Institute for Research in Immunology and Cancer CECR in Therapeutics Discovery)|Beauger, Nadine (Institut de recherche en immunologie et en cancérologie IRIC/CECR en découverte thérapeutique), recipient country : CA, recipient province : nan, recipient city : Quebec|Québec, recipient postal code : nan, program name english : Centres of Excellence for Commercialization and Research - Group, program name french : Centres d'excellence en commercialisation et en recherche - groupe, program purpose english : nan, program purpose french : nan, agreement title english : IRICoR - Institute for Research in Immunology and Cancer - Commercialization of Research / Institut de Recherche en Immunologie et en Cancérologie - Commercialisation de la Recherche, agreement title french : IRICoR - Institute for Research in Immunology and Cancer - Commercialization of Research / Institut de Recherche en Immunologie et en Cancérologie - Commercialisation de la Recherche, agreement number : CECGP, agreement value : 7550000.0, agreement start date : 2018-03-31, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2023-2024)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2023-2024)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada